Kutatási jelek – Signal Engine

• Performance of Machine Learning Models Based on Medical Imaging in Predicting Pathological Grade of Clear Cell Renal Cell Carcinoma — SCLC
• OS Therapies Reports Significant OST-HER2 Survival Data - OSTX — Prostate cancer
• An interim cancer‑trial analysis found 71.2% three‑year survival versus 45.8% in a historical group. — Prostate cancer
• Effect of a Nurse‑Navigated Game‑Based Program on Transition Readiness and Psychosocial Outcomes in Adolescents With Osteosarcoma: A Cluster‑Nonrandomized Controlled Study — Osteosarcoma
• Triple-Negative Breast Cancer — Breast cancer
• Integrated Immunotherapy Target Atlas for Ewing Sarcoma — Ewing sarcoma
• Comparative Efficacy of BTK Inhibitors in Treatment‑Naïve and Relapsed/Refractory Mantle Cell Lymphoma: A Systematic Review and Meta‑Analysis — Mantle cell lymphoma
• Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City — Prostate cancer
• How Acupuncture Can Support Recovery After Breast Cancer Treatment — Breast cancer
• Bladder preservation with systemic therapy alone: are we losing sight of survival? — Bladder cancer
• Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma — Multiple myeloma
• A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas — Nasopharyngeal carcinoma
• (P095) Comparison of Toxicity and Treatment Outcomes in HIV-Positive Versus HIV-Negative Patients With Squamous Cell Carcinoma of the Anal Canal | CancerNetwork — Thyroid cancer
• Doxil Wins Full Approval for Relapsed Ovarian Ca — Ovarian cancer
• Early Local Treatment Delays Multiple Metastases in Non‑Small Cell Lung Cancer With Solitary Distant Metastasis: A Multicenter Retrospective Cohort Study — NSCLC
• CAIX and CD70 Theranostics in Clear Cell Renal Cell Carcinoma: Navigating the Promise and Perils — Nasopharyngeal carcinoma
• Long-read sequencing reveals widespread novel splicing and neojunction-derived neoantigens in nasopharyngeal carcinoma — Nasopharyngeal carcinoma
• Shared Decision-Making in Early-Stage EGFR-Mutated NSCLC — NSCLC
• Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease — Pancreatic cancer
• KRAS Mutation Targeted Therapy: A Patient's Guide — Cholangiocarcinoma